Hs 602 (ATCC® HTB-142)

Organism: Homo sapiens, human  /  Disease: lymphoma

Organism Homo sapiens, human
Product Format frozen
Morphology single spherical or small clusters
Culture Properties suspension
Biosafety Level 1
Disease lymphoma
Gender female
Karyotype no Y chromosome noted
Clinical Data
female
Tumorigenic Yes
Effects
Yes, in anti lymphocyte serum treated and X-irradiated mice
Complete Growth Medium The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Establish new cultures at 3 X 10 exp5 cells/ml and maintain at between 4 X 10 exp5 and 1 X 10 exp6 cells/ml.
Cryopreservation
Culture medium, 95%; DMSO, 5%
Isoenzymes
ES-D, 1
G6PD, B
GLO-I, 1-2
PGM1, 1-2
Name of Depositor P Arnstein
References

Arnstein P, et al. Propagation of human tumors in antithymocyte serum-treated mice. J. Natl. Cancer Inst. 52: 71-84, 1974. PubMed: 4544026

Ohsugi Y, et al. Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X- irradiated nude mice. J. Natl. Cancer Inst. 65: 715-718, 1980. PubMed: 6932523

The cells are less tumorigenic in untreated nude mice.

Basic Documentation
References

Arnstein P, et al. Propagation of human tumors in antithymocyte serum-treated mice. J. Natl. Cancer Inst. 52: 71-84, 1974. PubMed: 4544026

Ohsugi Y, et al. Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X- irradiated nude mice. J. Natl. Cancer Inst. 65: 715-718, 1980. PubMed: 6932523

The cells are less tumorigenic in untreated nude mice.